Enhanced Group Inc. (ENHA) is a New York-based company operating in the sports entertainment, performance technology, and lifestyle wellness markets. Its business centers on two offerings. The first is the Enhanced Games, a live, multi-sport competition platform designed to showcase athletes pursuing world-record performances under medically supervised conditions. The second is Live Enhanced, a direct-to-consumer, clinician-guided wellness platform through which customers access supplements, prescription-based hormone therapy, and longevity-related protocols provided by third-party telehealth providers.
The company is positioning itself at the intersection of athletic performance, scientific innovation, and consumer health. Investors follow ENHA for its exposure to the growing health-optimization and longevity trend, though its revenue base is still developing and the business remains in an early stage relative to its broader market ambition.
Over the last 30 days, ENHA has fallen sharply. The stock closed near $14.70 on October 2 and has since declined to about $8.88, a drop of roughly 39.6%. The decline was not linear: the shares showed wide intraday ranges and multiple heavy-volume sessions, reflecting significant two-way trading amid a clearly downward bias. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The last quarter tells an even steeper story. After trading around $27 in early August, the stock has shed close to 68% of its value. This multi-month slide followed a period of notable volatility, including a sharp selloff in mid-August and continued weakness through September and October, punctuated by several large single-day percentage drops.
The most recent leg lower appears tied to financing and dilution concerns. A prospectus supplement relating to the company's Class A common stock was filed in the period, a development that can pressure shares when investors anticipate new issuance and share-count growth. Combined with thin trading liquidity relative to the stock's prior volatility, this contributed to outsized downward moves.
Broader sentiment has also deteriorated. ENHA's volatility reflects investor uncertainty about the company's near-term path to meaningful revenue and its capital needs as it continues to build out the Enhanced Games and Live Enhanced platforms. The absence of a clear, positive catalyst during the month left the stock vulnerable to selling pressure, with several sessions showing declines exceeding 20% amid elevated volume.
Over the full quarter, the dominant narrative has been a steady repricing of a stock that had traded at considerably higher levels earlier in the year. After a mid-August collapse—marked by very heavy volume and a multi-day selloff—the shares attempted to stabilize in the mid-teens before resuming their decline in October.
The quarter's weakness reflects a combination of factors: ongoing capital-raising activity and dilution, limited visibility into near-term revenue growth, and a broader reset in risk appetite for early-stage and speculative equities. While the company announced governance additions such as the appointment of a new independent director to its board and audit committee, these updates have not been enough to offset the persistent selling pressure across the period.
Looking ahead, investors should monitor the company's capital structure and any further share issuance, as dilution remains a central concern. Quarterly earnings and revenue updates will be critical for gauging whether the Enhanced Games and Live Enhanced platforms are gaining commercial traction. Macroeconomic conditions and risk appetite for speculative, early-stage equities will also influence the stock's direction, as will any announcements around partnerships, event scheduling for the Enhanced Games, and expansion of the telehealth-driven wellness offering. Competitive pressures and regulatory considerations in the health and wellness space are additional factors worth tracking.
In my research process, I frequently review Tickeron’s AI Trading Bots to gain perspective on automated strategies that are active across volatile names. These tools surface top-performing bots with different holding timeframes and approaches, allowing me to cross-check momentum signals without relying on a single method. It adds a useful layer when evaluating names like ENHA that have seen sharp swings. AI Trading Bots
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Indicator for ENHA moved out of oversold territory on October 12, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 9 similar instances when the indicator left oversold territory. In 9 of the 9 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 5 of 10 cases where ENHA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 50%.
The Moving Average Convergence Divergence (MACD) for ENHA just turned positive on October 28, 2026. Looking at past instances where ENHA's MACD turned positive, the stock continued to rise in 4 of 9 cases over the following month. The odds of a continued upward trend are 44%.
Following a +19.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where ENHA advanced for three days, in 18 of 35 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.
ENHA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ENHA as a result. In 5 of 17 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 29%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENHA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for ENHA entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. ENHA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ENHA's P/B Ratio (420.608) is very high in comparison to the industry average of (7.678). P/E Ratio (-12.320) is within average values for comparable stocks, (6.461). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (10.417) is also within normal values, averaging (5.003).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENHA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry FoodMajorDiversified